Advertisement
Screener

Canopy Growth Corp (CGC) Debt Instrument, Fair Value Disclosure

Canopy Growth Corp Debt Instrument, Fair Value Disclosure

Canopy Growth Corp (CGC) had Debt Instrument, Fair Value Disclosure of CAD 59.91 million as of 2024-03-31, per its 10-K filed 2024-05-30.

Discontinued › Notes

us-gaap:DebtInstrumentFairValue · last filed 2024-05-30

  • 2024-03-31: Debt Instrument, Fair Value Disclosure 59.91M CAD.
  • 2023-03-31: Debt Instrument, Fair Value Disclosure 75.01M CAD.
  • 2022-12-09: Debt Instrument, Fair Value Disclosure 89.09M CAD.
  • 2022-05-17: Debt Instrument, Fair Value Disclosure 90.12M CAD.
Period endDebt Instrument, Fair Value Disclosure
2024-03-3159.91M CAD
10-K · filed 2024-05-30
2023-03-3175.01M CAD
10-K · filed 2024-05-30
2022-12-0989.09M CAD
10-K · filed 2024-05-30
2022-05-1790.12M CAD
10-K · filed 2024-05-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87